Using Short Message Service as a Means of Clinical Engagement in Early Psychosis

Psychotic Disorders Clinical Trial

Official title:

Using Short Message Service as a Means of Clinical Engagement in Early Psychosis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04379349
• Other study ID #: 091-2017
• Status: Completed
• Phase: N/A
• Start date: January 1, 2018
• Est. completion date: March 31, 2020

Study information

• Verified date: May 2020
• Source: Centre for Addiction and Mental Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Engagement with clinical services for youth with early psychosis represents a significant challenge, with up to 40% of patients dropping out of treatment in the first year. This has been linked to worse illness outcomes and represents a significant barrier to recovery for these patients. This study aims to evaluate the efficacy of short message service (SMS) as a means of improving clinical engagement in early-episode psychosis populations by bridging contact between appointments with weekly check-ins/reminders. These weekly check-ins during the first year of treatment will serve as an additional opportunity to reach out to patients and give them a chance to do the same with their care teams, with patient responses triggering clinician follow-up if necessary.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 61
• Est. completion date: March 31, 2020
• Est. primary completion date: March 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years to 29 Years

Eligibility

Inclusion Criteria:

• between the ages of 16-29

• a diagnosis of an affective or non-affective psychotic disorder (i.e., Bipolar or Major Depressive Disorders with Psychotic Features, Schizophrenia Spectrum Disorders, Other Specified Psychotic Disorders, Substance Induced Psychosis and Attenuated Psychotic Syndrome)

• eligible for follow-up within the Slaight Family Centre for Youth in Transition early intervention service

• within the first 6 months of treatment

Exclusion Criteria:

• involved in another intervention study

• do not have a personal cell phone number

Related Conditions & MeSH terms

• Mental Disorders
• Psychotic Disorders

Intervention

Behavioral:
• SMS text messaging - interactive check-in
Interactive SMS text message check-ins delivered once weekly to participants.
• SMS text messaging - inactive control
Minimally interactive SMS text message delivered once weekly to participants.

Locations

Country	Name	City	State
Canada	Centre for Addiction and Mental Health	Toronto	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
Centre for Addiction and Mental Health

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Service Engagement Scale (SES)	Clinician-rated treatment engagement and adherence (minimum score = 0, maximum score = 42, higher score indicates worse service engagement)	9 months
Primary	Appointment Attendance	Percentage of attended clinic appointments	9 months
Secondary	Emergency Department Visits	Number of emergency department visits	9 months
Secondary	Hospitalizations	Number of hospitalizations	9 months
Secondary	Social Functioning Scale (SFS)	Self-report measure of social functioning (minimum score = 0, maximum score = 247, higher score indicates better functioning)	9 months
Secondary	Personal and Social Performance Scale (PSP)	Interview-rated measure of global functioning (minimum score = 1, maximum score = 100, higher score indicates better functioning)	9 months
Secondary	Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LESQ-18)	Self-reported measure of subjective quality of life (minimum score = 1, maximum score = 5, higher score indicates better quality of life)	9 months
Secondary	Clinical Global Impression (CGI)	Interview-based global rating of illness severity (minimum score = 1, maximum score = 7, higher score indicates worse illness severity)	9 months
Secondary	Brief Psychiatric Rating Scale (BPRS)	Interview-based measure of the severity of psychiatric symptoms (minimum score = 24, maximum score = 168, higher score indicates higher severity of symptoms)	9 months
Secondary	Scale for the Assessment of Negative Symptoms (SANS)	Interview-based measure of the severity of negative symptoms (minimum score = 0, maximum score = 110, higher score indicates higher severity of symptoms)	9 months
Secondary	Apathy Evaluation Scale (AES)	Interview-rated measure of the severity of motivation deficits (minimum score = 18, maximum score = 72, higher score indicates worse motivation deficits)	9 months
Secondary	Brief Cognitive Assessment Tool for Schizophrenia (B-CATS)	Rater-administered measure of cognitive functioning (scores indicate standardized Z-scores with no pre-defined minimum or maximum score, higher score indicates better cognitive functioning)	9 months
Secondary	Drug Attitude Inventory (DAI-10)	Self-reported measure of medication adherence (minimum score = -10, maximum score = + 10, higher score indicates better adherence)	9 months
Secondary	Scale To Assess Therapeutic Relationships - Patient Version (STAR-P)	Self-reported measure of the clinician-patient therapeutic relationship (minimum score = 0, maximum score = 48, higher score indicates better therapeutic relationship)	9 months